Omega Fund IV GP, L.P. is Director & 10% Owner at Replimune Group, Inc. (REPL). They have made 6 open-market trades across 2 companies since 2021, most recently 2021-12-15.
CIK 0001528383
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 67% | 100% | 100% |
| Avg Move | -7.6% | -19.5% | -43.1% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NUVB | SELL | 2021-12-15 | 2021-12-17 | $10.07 | $5.0M | +0.7% | -33.0% | -36.7% |
| REPL | SELL | 2021-11-19 | 2021-11-23 | $34.58 | $3.1M | -16.1% | -11.1% | -50.4% |
| REPL | SELL · 10b5-1 | 2021-11-16 | 2021-11-18 | $33.50 | $87K | -17.1% | -21.7% | -48.0% |
| REPL | SELL | 2021-11-12 | 2021-11-16 | $33.66 | $1.6M | -14.0% | -23.6% | -49.1% |
| REPL | SELL | 2021-11-10 | 2021-11-12 | $33.61 | $1.2M | -8.0% | -16.7% | -46.7% |
| REPL | SELL | 2021-11-08 | 2021-11-10 | $33.66 | $764K | +1.5% | -17.3% | -44.4% |
| REPL | SELL | 2021-01-14 | 2021-01-19 | $45.10 | $1.8M | -9.8% | -15.7% | -31.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.